Gammaglobulin level after rituximab therapy for ITP
| Date . | No. of tested patients . | Gammaglobulin level (g/dL), median (Q1-3) . | No. of patients with gammaglobulin level ≥5 and <8 g/dL . | No. of patients with gammaglobulin level <5 g/dL . |
|---|---|---|---|---|
| Month 2 | 44 | 10.21 (6.2-19.8) | 9 | 0 |
| Month 4 | 45 | 9.96 (5.7-21) | 11 | 0 |
| Month 6 | 37 | 9.61 (5.4-20.2) | 13 | 0 |
| Month 12 | 43 | 10.09 (5.49-25.8) | 6 | 0 |
| Month 18 | 29 | 11.01 (7.2-17.2) | 2 | 0 |
| Month 24 | 30 | 11.78 (3.66-39.7) | 6 | 1 |
| Date . | No. of tested patients . | Gammaglobulin level (g/dL), median (Q1-3) . | No. of patients with gammaglobulin level ≥5 and <8 g/dL . | No. of patients with gammaglobulin level <5 g/dL . |
|---|---|---|---|---|
| Month 2 | 44 | 10.21 (6.2-19.8) | 9 | 0 |
| Month 4 | 45 | 9.96 (5.7-21) | 11 | 0 |
| Month 6 | 37 | 9.61 (5.4-20.2) | 13 | 0 |
| Month 12 | 43 | 10.09 (5.49-25.8) | 6 | 0 |
| Month 18 | 29 | 11.01 (7.2-17.2) | 2 | 0 |
| Month 24 | 30 | 11.78 (3.66-39.7) | 6 | 1 |